Ischemic preconditioning attenuates ischemia/reperfusion-induced activation of caspases and subsequent cleavage of poly(ADP-ribose) polymerase in rat hearts in vivo

Cardiovascular Research

Volumn 44, Issue 3, 1999, Pages 536-542

  Piot, Christophe A ^a,c   Martini, Jean François ^b   Bui, Steve K ^a   Wolfe, Christopher L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c HÔPITAL ARNAUD DE VILLENEUVE   (France)

Author keywords

Apoptosis; Ischemia; Preconditioning; Reperfusion

Indexed keywords

CASPASE; CASPASE 3; DNA FRAGMENT; INTERLEUKIN 1BETA CONVERTING ENZYME; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; NONHUMAN; NUCLEOSOME; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT; REPERFUSION INJURY; WESTERN BLOTTING;

ANALYSIS OF VARIANCE; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CASPASE 1; CASPASE 3; CASPASES; DNA FRAGMENTATION; ENZYME PRECURSORS; ENZYME REPRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; POLY(ADP-RIBOSE) POLYMERASES; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER;

EID: 0033407159     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(99)00227-8     Document Type: Article

References (44)

1. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986;74:1124-1136.
2. Schott RJ, Rohmann S, Braun ER, Schaper W. Ischemic preconditioning reduces infarct size in swine myocardium. Circ Res 1990;66:113-142.
3. Cohen MV, Liu GS, Downey JM. Preconditioning causes improved wall motion as well as smaller infarcts after transient coronary occlusion in rabbits. Circulation 1991;84:341-349.
4. Liu Y, Downey JM. Ischemic preconditioning protects against infarction in rat heart. Am J Physiol 1992;263:H1107-H1112.
5. Wolfe CL, Sievers RE, Visseren EL, Donnelly TJ. Loss of myocardial protection after preconditioning correlates with the time course of glycogen recovery within the preconditioned segment. Circulation 1993;87:881-892.
6. Barbosa V, Sievers RE, Zaugg CE, Wolfe CL. Preconditioning ischemia time determines the degree of glycogen depletion and infarct size reduction in rat hearts. Am Heart J 1996;131:224-230.
7. Yellon DM, Alkhulaifi AM, Pugsley WB. Preconditioning the human myocardium. Lancet 1993;342:276-277.
8. Ottani E, Galvani M, Ferrini D et al. Prodromal angina limits infarct size: a role for ischemic preconditioning. Circulation 1995;91:291-297.
9. Gottlieb RA, Gruol DL, Zhu JY, Engler RL. Preconditioning in rabbit cardiomyocytes. Role of pH, vacuolar proton ATPase, and apoptosis. J Clin Invest 1996;97:2391-2398.
10. Piot C, Padmanaban D, Ursell PC, Sievers RE, Wolfe CL. Ischemic preconditioning decreases apoptosis in rat hearts in vivo. Circulation 1997;96:1598-1604.
11. Maulik N, Yoshida T, Engelman RM et al. Ischemic preconditioning attenuates apoptotic cell death associated with ischemia/reperfusion. Mol Cell Biochem 1998;186:139-145.
12. Williams GT, Smith CA. Molecular regulation of apoptosis: genetic controls on cell death. Cell 1993;74:777-779.
13. Martin SJ, Green DR. Protease activation during apoptosis: death by thousand cuts? Cell 1995;82:349-352.
14. Thornberry NA, Lazebnik Y. Caspases: enemies within. Science 1998;281:1312-1316.
15. Yuan J, Shaham S, Ledoux S, Ellis HM, Horvitz HR. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme. Cell 1993;75:641-652.
16. Thornberry NA, Bull HG, Calaycay JR et al. A novel heterodimeric cysteine protease is required for interleukin-1β-processing in monocytes. Nature 1992;356:768-774.
17. Nicholson DW, Ali A, Thornberry NA et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 1995;376:37-43.
18. Tewari M, Quan LT, O'Rourke K et al. Yama/CPP32β, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell 1995;81:801-809.
19. Lazebnik YA, Kaufmann SH, Desnoyers S, Poirier GG, Earnshaw WC. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 1994;371:346-347.
20. Gu Y, Sarnecki C, Aldape RA, Livingston DJ, Su MS. Cleavage of poly(ADP-ribose) polymerase by interleukin-1-β-converting enzyme and its homologs TX and Nedd-2. J Biol Chem 1995;270:18715-18718.
21. Yaoita H, Ogawa K, Maehara K, Maruyama Y. Attenuation of ischemia/reperfusion injury in rats by a caspase inhibitor. Circulation 1998;97:276-281.
22. Keane KM, Giegel DA, Lipinski WJ, Callahan MJ, Shivers BD. Cloning, tissue expression and regulation of rat interleukin 1 beta converting enzyme. Cytokine 1995;7:105-110.
23. Gottlieb RA, Burleson KO, Kloner RA, Babior BM, Engler RL. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest 1994;94:1621-1628.
24. Kajstura J, Cheng W, Reiss K et al. Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab Invest 1996;74:86-107.
25. Piot C, Wolfe CL. Apoptosis: a new mechanism of lethal myocardial reperfusion injury? J Thromb Thrombolysis 1997;4:67-68.
26. Black SC, Huang JQ, Rezaiefar P et al. Co-localization of the cysteine protease caspase-3 with apoptotic myocytes after in vivo myocardial ischemia and reperfusion in the rat. J Mol Cell Cardiol 1998;30:733-742.
27. Laderoute KR, Webster KA. Hypoxia/reoxygenation stimulates jun kinase activity through redox signaling in cardiac myocytes. Circ Res 1997;80:336-344.
28. Bielawska AE, Shapiro JP, Jiang L et al. Ceramide is involved in triggering of cardiomyocyte apoptosis induced by ischemia and reperfusion. Am J Pathol 1997;151:1257-1263.
29. Enari M, Talanian RV, Wong WW, Nagata S. Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis. Nature 1996;380:723-726.
30. Verheij M, Bose R, Lin XH et al. Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature 1996;380:75-79.
31. Goillot E, Raingeaud J, Ranger A et al. Mitogen-activated protein kinase-mediated Fas apoptotic signaling pathway. Proc Natl Acad Sci USA 1997;94:3302-3307.
32. Ashkenazi A, Dixit VM. Death receptors: signaling and modulation. Science 1998;281:1305-1308.
33. Wang NP, Bufkin BE, Nakamura M et al. Ischemic preconditioning reduces neutrophil accumulation and myocardial apoptosis. Ann Thorac Surg 1999;67:1689-1695.
34. Li Y, Kloner RA. Does protein kinase C play a role in ischemic preconditioning in rat hearts? Am J Physiol 1995;268:H426-H431.
35. Speechly-Dick ME, Mocanu MM, Yellon DM. Protein kinase C. Its role in ischemic preconditioning in the rat. Cire Res 1994;75:586-590.
36. Kida M, Fujiwara H, Ishida M et al. Ischemie preconditioning preserves creatine phosphate and intracellular pH. Circulation 1991;84:2495-2503.
37. de Albuquerque CP, Gerstenblith G, Weiss RG. Importance of metabolic inhibition and cellular pH in mediating preconditioning contractile and metabolic effects in rat hearts. Circ Res 1994;74:139-150.
38. 2+ , and apoptosis in neonatal cardiomyocytes during metabolic inhibition/recovery. Circ Res 1998;82:1139-1144.
39. Maulik N, Watanabe M, Zu Y et al. Ischemic preconditioning triggers the activation of MAP kinases and MAPKAP kinase 2 in rat hearts. FEBS Lett 1996;396:233-237.
40. Sheng Z, Knowlton K, Chen J et al. Cardiotrophin 1 (CT-1) inhibition of cardiac myocyte apoptosis via a mitogen-activated protein kinase-dependent pathway. J Biol Chem 1997;272:5783-5791.
41. Xia Z, Dickens M, Raingeaud J et al. Opposing effects of ERK and JNP-p38 MAP kinases on apoptosis. Science 1995;270:1326-1331.
42. Buerke M, Murohara T, Skurk C et al. Cardioprotective effect of insulin-like growth factor I in myocardial ischemia followed by reperfusion. Proc Natl Acad Sci USA 1995;92:8031-8035.
43. Fliss H, Gattinger D. Apoptosis in ischemic and reperfused myocardium. Circ Res 1996;79:949-956.
44. Vakeva AP, Agah A, Rollins SA et al. Myocardial infarction and apoptosis after myocardial ischemia and reperfusion: role of the terminal complement components and inhibition by anti-C5 therapy. Circulation 1998;97:2259-2267.